New drug trial aims to better control anemia for kidney patients
NCT ID NCT07487727
Summary
This study is testing a new drug called AND017 to see if it can safely and effectively manage anemia in people with chronic kidney disease who are not on dialysis. It will compare AND017 to an existing treatment to see which one does a better job of keeping patients' red blood cell levels stable over time. The goal is to find a new option to control this common and tiring complication of kidney disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA DUE TO CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100044, China
Contact
Conditions
Explore the condition pages connected to this study.